Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$5.4B |
| 2 |
NVIDIA
NVDA
|
+$388M |
| 3 |
Microsoft
MSFT
|
+$182M |
| 4 |
Amazon
AMZN
|
+$177M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$163M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$213M |
| 2 |
Broadcom
AVGO
|
+$103M |
| 3 |
Union Pacific
UNP
|
+$100M |
| 4 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$89.9M |
| 5 |
Marvell Technology
MRVL
|
+$89.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.68% |
| 2 | Industrials | 8.46% |
| 3 | Financials | 6.55% |
| 4 | Consumer Discretionary | 5.99% |
| 5 | Healthcare | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
PUT
Coinbase
COIN
$49.2B
| $5.65M | 0.03% |
25,000
+10,600
| +74% | +$3.16M |
|
502
East-West Bancorp
EWBC
$17.8B
| $5.63M | 0.02% |
50,056
+32,558
| +186% | +$3.46M |
|
503
TJX Companies
TJX
$155B
| $5.61M | 0.02% |
36,505
-53,588
| -59% | -$7.93M |
|
504
Cigna
CI
$73.3B
| $5.6M | 0.02% |
+20,353
| New | +$5.71M |
|
505
Molson Coors Class B
TAP
$8.01B
| $5.58M | 0.02% |
119,607
-22,642
| -16% | -$1.04M |
|
|
LGN
506
Legence Corp
LGN
$4.57B
| $5.55M | 0.02% |
128,995
-141,171
| -52% | -$5.58M |
|
507
Shell
SHEL
$257B
| $5.51M | 0.02% |
74,925
+19,125
| +34% | +$1.41M |
|
|
KBONU
508
Karbon Capital Partners Corp Units
KBONU
$317M
| $5.49M | 0.02% |
+545,511
| New | +$5.49M |
|
509
Sanofi
SNY
$110B
| $5.47M | 0.02% |
112,966
+112,894
| +156,797% | +$5.6M |
|
|
MRSH
510
Marsh
MRSH
$91.6B
| $5.44M | 0.02% |
29,323
-25,120
| -46% | -$4.7M |
|
511
McKesson
MCK
$100B
| $5.43M | 0.02% |
6,617
+5,801
| +711% | +$4.73M |
|
512
Valaris
VAL
$6.09B
| $5.41M | 0.02% |
107,259
+71,616
| +201% | +$3.84M |
|
513
Ondas Inc
ONDS
$4.97B
| $5.36M | 0.02% |
+548,919
| New | +$4.41M |
|
514
LPL Financial
LPLA
$28.5B
| $5.35M | 0.02% |
+14,983
| New | +$5.3M |
|
515
Harmony Gold Mining
HMY
$14.7B
| $5.33M | 0.02% |
267,816
+219,936
| +459% | +$4.1M |
|
516
BILL Holdings
BILL
$4.76B
| $5.31M | 0.02% |
+97,439
| New | +$5.01M |
|
517
The Ensign Group
ENSG
$10.5B
| $5.29M | 0.02% |
30,391
+22,664
| +293% | +$4.07M |
|
518
HubSpot
HUBS
$12B
| $5.29M | 0.02% |
13,187
+7,292
| +124% | +$3.02M |
|
519
Advance Auto Parts
AAP
$2.57B
| $5.29M | 0.02% |
134,613
+96,197
| +250% | +$4.82M |
|
520
Avis
CAR
$5.18B
| $5.29M | 0.02% |
41,199
+4,494
| +12% | +$627K |
|
521
AutoZone
AZO
$48.3B
| $5.28M | 0.02% |
1,558
-2,847
| -65% | -$10.8M |
|
|
MBX
522
MBX Biosciences
MBX
$3.19B
| $5.27M | 0.02% |
167,125
-115,552
| -41% | -$2.8M |
|
523
GSK
GSK
$105B
| $5.26M | 0.02% |
107,251
-242,667
| -69% | -$11.3M |
|
524
Yeti Holdings
YETI
$3.19B
| $5.22M | 0.02% |
118,122
+92,306
| +358% | +$3.55M |
|
|
HSAI
525
Hesai Group
HSAI
$3B
| $5.19M | 0.02% |
231,893
+19,056
| +9% | +$417K |
|
Similar funds
Steve Schonfeld's Q4 2025 Portfolio in Review
As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.
- Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
- Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
- Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
- Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
- Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
- Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.